Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts

Clinical Chemistry

Volumn 47, Issue 3, 2001, Pages 477-485

  Bonafe L ^a   Thony B ^a   Leimbacher, W ^a   Kierat, L ^a   Blau, N ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE; BIOPTERIN; CYTOKINE; DIHYDROPTERIDINE REDUCTASE; DOPA; DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; SEPIAPTERIN REDUCTASE; TETRAHYDROBIOPTERIN;

ADOLESCENT; ADULT; ARTICLE; CELL METABOLISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DYSTONIA; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; HUMAN; HUMAN CELL; MALE; SCHOOL CHILD; SKIN FIBROBLAST;

EID: 0035099949     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.3.477     Document Type: Article

References (46)

1. Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse
2. Tetrahydrobiopterin and cytokines
3. Tetrahydrobiopterin biosynthesis, regeneration, and functions
4. Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes
5. Molecular basis of dihydropteridine reductase deficiency
6. Disorders of tetrahydrobiopterin and related biogenic amines
7. Hereditary progressive dystonia with marked diurnal fluctuation and dopa-responsive dystonia: Pathognomonic clinical features
8. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis
9. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q
10. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutation in the GTP cyclohydrolase I gene
11. Dopa-responsive dystonia: Recent advances and remaining issues to be addressed
12. Gender-related penetrance and de novo GTP cyclohydrolase I gene mutations in dopa-responsive dystonia
13. High penetrance and pronounced variation in expressivity of GCH1 mutations in five families with Dopa-responsive dystonia
14. Dopa-responsive dystonia: Long term treatment response and prognosis
15. Strategy for the screening of tetrahydrobiopterin deffciency among hyperphenylalaninaemic patients: 15-years experience
16. Dystonia with marked diurnal variation associated with biopterin deficiency
17. Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: Absence of phosphate-eliminating enzyme activity demonstrated in liver
18. Phenylketonuria due to a deficiency of dihydropteridine reductase
19. Tetrahydrobiopterin deficiency: Assay for 6-pyruvoyl-tetrahydropterin synthase activity in erythrocytes, and detection of patients and heterozygous carriers
20. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: Diagnosis by enzyme assays on dried blood spots
21. 6-pyruvoyl-tetrahydropterin synthase in human tissues and cell lines
22. Hyperphenylalaninemia due to dihydropteridine reductase deficiency. Assay of the enzyme in fibroblasts from affected infants, heterozygotes, and in normal amniotic fluid cells
23. Guanosine triphosphate cyclohydrolase I assay in human and rat liver using high-performance liquid chromatography of neopterin phosphates and guanine nucleotides
24. Increase of GTP cyclohydrolase I activity in mononuclear blood cells by stimulation: Detection of heterozygotes of GTP cyclohydrolase I deficiency
25. Normal values and age-dependent changes in GTP cyclohydrolase I activity in stimulated mononuclear blood cells measured by high-performance liquid chromatography
26. Tetrahydrobiopterin biosynthesis defects examined in cytokine-stimulated fibroblasts
27. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-γ
28. Immobilization of GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase to different affinity supports
29. Mammalian chromosome identification in interspecific hybride cells using "Hoechst 33258"
30. Pterins
31. A sensitive assay for the enzymatic activity of GTP cyclohydrolase I
32. Sepiapterin reductase in human amniotic and skin fibroblasts, chorionic villi, and various blood fractions
33. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
34. Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin
35. Neurotransmitter therapy and diet in malignant phenylketonuria
36. Oral phenylalanine loading in Dopa-responsive dystonia - A possible diagnostic test
37. Plasma phenylalanine and tyrosine levels revisited in heterozygotes for hyperphenylalaninemia
38. Markers of disease in dopa-responsive dystonia
39. Differential diagnosis of disorders of biogenic amines metabolism
40. Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia
41. Dopa-responsive dystonia in British patients - New mutations of the GTP cyclohydrolase I gene and evidence for genetic heterogeneity
42. Characterization of wild type and mutants of recombinant human GTP cyclohydrolase I: Relationship to etiology of Dopa-responsive dystonia
43. Dominant negative effect of GTP cyclohydrolase I mutations in dopa-responsive hereditary progressive dystonia
44. Mutant GTP cyclohydrolase I in autosomal dominant dystonia and recessive hyperphenylalaninemia